Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience: Patrick Finn

Twist Bioscience has promoted Patrick Finn to the newly created position of president and chief operating officer. Finn previously served as chief commercial officer at Twist. He joined the company in 2015 and was promoted to CCO in 2019. Prior to Twist, Finn was at Enzymatics (now part of Qiagen), where he was VP of sales, leading commercial activities for North America and Europe. Prior to Enzymatics, he held positions of increasing responsibility, including director of business development, at Agilent Technologies. Finn also previously worked for Beckman Coulter, Invitrogen, and GE Healthcare/Amersham International. He holds a PhD in nucleic acid chemistry from Southampton University and a BSc Hons in chemistry from Heriot-Watt University.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.